Atlas Trials

TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC

Clinical trial NCT07697898 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07697898
Sponsor
Tongji Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2026-07-01
Primary completion
2030-12-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.